Does SELEXIPAG Cause Basal cell carcinoma? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Basal cell carcinoma have been filed in association with SELEXIPAG (Selexipag). This represents 0.1% of all adverse event reports for SELEXIPAG.
9
Reports of Basal cell carcinoma with SELEXIPAG
0.1%
of all SELEXIPAG reports
1
Deaths
3
Hospitalizations
How Dangerous Is Basal cell carcinoma From SELEXIPAG?
Of the 9 reports, 1 (11.1%) resulted in death, 3 (33.3%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELEXIPAG. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does SELEXIPAG Cause?
Headache (5,693)
Diarrhoea (4,341)
Dyspnoea (3,705)
Nausea (3,392)
Pain in jaw (2,072)
Fatigue (2,009)
Death (1,893)
Pain (1,870)
Pain in extremity (1,797)
Dizziness (1,796)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which SELEXIPAG Alternatives Have Lower Basal cell carcinoma Risk?
SELEXIPAG vs SELINEXOR
SELEXIPAG vs SELPERCATINIB
SELEXIPAG vs SELUMETINIB
SELEXIPAG vs SEMAGLUTIDE
SELEXIPAG vs SEMUSTINE